| Online-Ressource |
Verfasst von: | Söhnlein, Petra [VerfasserIn]  |
| Müller, M. [VerfasserIn]  |
| Syren, K. [VerfasserIn]  |
| Hartmann, U. [VerfasserIn]  |
| Böhm, B. O. [VerfasserIn]  |
| Meinck, Hans-Michael [VerfasserIn]  |
| Knip, M. [VerfasserIn]  |
| Akerblom, H. K. [VerfasserIn]  |
| Richter, Wiltrud [VerfasserIn]  |
Titel: | Epitope spreading and a varying but not disease-specific GAD65 antibody response in Type I diabetes |
Verf.angabe: | P. Söhnlein, M. Müller, K. Syren, U. Hartmann, B.O. Böhm, H.M. Meinck, M. Knip, H.K. Akerblom, The Childhood Diabetes in Finland Study Group, W. Richter |
Jahr: | 2000 |
Umfang: | 8 S. |
Teil: | volume:43 |
| year:2000 |
| number:2 |
| pages:210-217 |
| extent:8 |
Fussnoten: | Gesehen am 04.03.2021 |
Titel Quelle: | Enthalten in: Diabetologia |
Ort Quelle: | Berlin : Springer, 1965 |
Jahr Quelle: | 2000 |
Band/Heft Quelle: | 43(2000), 2, Seite 210-217 |
ISSN Quelle: | 1432-0428 |
Abstract: | Aims/hypothesis. The aim of this study was to analyse the conformational and linear epitope profiles of glutamic acid decarboxylase antibody (GAD65-ab)-positive sera to find disease-specific epitope profiles and to study, whether GAD65-ab epitope recognition changes or spreads during the prediabetic period and, thus, can provide markers to differentiate early from later stages of progression to diabetes.¶Methods. Sera from subjects before (n = 21), at onset (n = 44), or at increased risk of Type I (insulin-dependent) diabetes mellitus (n = 20) and from patients with stiff-man syndrome (SMS, n = 18) or polyendocrine autoimmune syndrome (PAS, n = 21) were analysed for conformational and linear GAD65 epitope recognition by an immunohistochemical blocking test based on human monoclonal GAD65-ab (MICA 1-10) and western blotting of a GAD65 epitope-cDNA-library.¶Results. A redundant reactivity of many GAD65-ab positive sera to three major conformational (EP-1, EP-2, EP-3) and two dominant linear epitope clusters (amino acid 1-124 and 535-585) was observed in diabetes, polyendocrine autoimmune syndrome and stiff-man syndrome and no disease-specific epitopes or epitope-profiles were detected. Epitope recognition broadened with higher titres and with the vulnerability of patients to acquire additional autoimmune diseases apart from diabetes. Low GAD65-ab serum titres ( < 1200 arbitrary units) and EP-1 recognition in the absence of EP-2 binding characterised the early immune response. Changing epitope profiles combined stable recognition of EP-1 with gain or loss of reactivity to C-terminal epitopes during follow-up.¶Conclusion/interpretation. A maturing autoantibody response, which could spread from EP-1-recognition to other regions of GAD65, resulted in titre-related rather than disease-specific epitope profiles which were not sufficient to predict whether GAD65-ab positive subjects will progress to Type I diabetes, autoimmune polyendocrine syndrome or stiff-man syndrome. |
DOI: | doi:10.1007/s001250050031 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext: https://doi.org/10.1007/s001250050031 |
| DOI: https://doi.org/10.1007/s001250050031 |
Datenträger: | Online-Ressource |
Sprache: | eng |
K10plus-PPN: | 1750414414 |
Verknüpfungen: | → Zeitschrift |
Epitope spreading and a varying but not disease-specific GAD65 antibody response in Type I diabetes / Söhnlein, Petra [VerfasserIn]; 2000 (Online-Ressource)